ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR)

145 filings reported holding ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") as of Q2 2018.
ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) has 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 51,724,461 shares of 138,764,349 outstanding shares and own 37% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (8,299,542 shares), OppenheimerFunds, Inc. (7,810,039 shares), BlackRock Inc. (7,083,926 shares), FIRST MANHATTAN CO (4,530,250 shares), STATE STREET CORP (4,031,856 shares), VANGUARD GROUP INC (3,941,108 shares), Vivo Capital, LLC (1,900,000 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1,503,500 shares), NORTHERN TRUST CORP (1,063,499 shares), and ACUTA CAPITAL PARTNERS, LLC (1,030,330 shares).
This table shows the top 114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.